1. Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4:566–572. [PubMed] [Google Scholar]
2. Streitz JM, Andrews CW, Ellis FH. Endoscopic surveillance of Barrett’s esophagus. J Thorac Cardiovasc Surg. 1993;105:383–388. [PubMed] [Google Scholar]
3. Peters JH, Clark GWB, Ireland AP, et al. Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg. 1994;108:811–822. [PubMed] [Google Scholar]
4. vanSandick J, vanLanschot J, Kuiken B, et al. Impact of endoscopic biopsy of surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut. 1998;43:216–22. [PMC free article] [PubMed] [Google Scholar]
5. Spechler SJ, Goyal RK. Barrett’s esophagus. N Engl J Med. 1986;315:362–371. [PubMed] [Google Scholar]
6. Williamson WA, Ellis FH, Gibb SP, et al. Barrett’s esophagus: Prevalence and incidence of adenocarcinoma. Arch Intern Med. 1991;151:2212–6. [PubMed] [Google Scholar]
7. Kabat GC, Ng SK, Wynder EL. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control. 1993;4:123–32. [PubMed] [Google Scholar]
8. Brown LM, Swanson CA, Gridley G, et al. Adenocarcinoma of the esophagus: Role of obesity and diet. J Natl Cancer Inst. 1995;87:104–9. [PubMed] [Google Scholar]
9. Vaughan TL, Davis S, Kristal A, et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995;4:85–92. [PubMed] [Google Scholar]
10. Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997;89:1277–84. [PubMed] [Google Scholar]
11. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150–5. [PubMed] [Google Scholar]
12. Wang KK, Wongkeesong M, Buttar NS, et al. American Gastroenterological Association medical position statement: Role of the gastroenterologist in the management of esophageal carcinoma. Gastroenterology. 2005;128:1468–70. [PubMed] [Google Scholar]
13. Hirota WK, Zuckerman MJ, Adler DG, et al. ASGE guideline. The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63:570–80. [PubMed] [Google Scholar]
14. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol. 1998;103:788–97. [PubMed] [Google Scholar]
15. Lagergren J, Bergstrom R, Lindgren A, et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer. 2000;85:340–6. [PubMed] [Google Scholar]
16. Chak A, Faulx A, Eng C, et al. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer. 2006;107:2160–6. [PubMed] [Google Scholar]
17. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831. [PubMed] [Google Scholar]
18. Reavis KM, Morris CD, Gopal DV, et al. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Ann Surg. 2004;239:849–856. [PMC free article] [PubMed] [Google Scholar]
19. Inadomi JM, Sampliner R, Lagergren J, et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med. 2003;138:176–186. [PubMed] [Google Scholar]
20. Nietert PJ, Silverstein MD, Mokhashi MS, et al. Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointest Endosc. 2003;57:311–318. [PubMed] [Google Scholar]
21. Rubenstein JH, Inadomi JM, Brill JV, et al. Cost utility of screening for Barrett’s esophagus with esophageal capsule endoscopy versus conventional upper endoscopy. Clin Gastroenterol Hepatol. 2007;5:312–8. [PubMed] [Google Scholar]
22. Gerson LB, Groeneveld PW, Triadafilopoulos G. Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2004;2:868–879. [PubMed] [Google Scholar]
23. Gerson L, Lin OS. Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett’s esophagus. Clin Gastroenterol Hepatol. 2007;5:319–325. [PubMed] [Google Scholar]
24. Barbiere J, Lyratzopoulos G. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett’s Esophagus. A review. Gastroenterology. (in press) [PubMed] [Google Scholar]
25. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: The Prague C & M criteria. Gastroenterology. 2006;131:1329–9. [PubMed] [Google Scholar]
26. Amano Y, Ishimura N, Furuta K, et al. Which landmark results in a more consistent diagnosis of Barrett’s esophagus, the gastric folds or palisade vessels? Gastrointest Endosc. 2006;64(2):206–211. [PubMed] [Google Scholar]
27. Wilkins T, Gillies RA. Office-based unsedated ultrathin esophagoscopy in a primary care setting. Ann Fam Med. 2005;3:126–30. [PMC free article] [PubMed] [Google Scholar]
28. Madhotra R, Mokhashi M, Willner I, et al. Prospective evaluation of a 3.1-mm battery-powered esophagoscope in screening for esophageal varices in cirrhotic patient. Am J Gastroenterol. 2003;98:807–12. [PubMed] [Google Scholar]
29. Thota PN, Zuccaro G, Jr, Vargo JJ, 2nd, et al. A randomized prospective trial comparing unsedated esophagoscopy via transnasal and transoral routes using a 4-mm video endoscope with conventional endoscopy with sedation. Endoscopy. 2005;37:559–65. [PubMed] [Google Scholar]
30. Faulx AL, Catanzaro A, Zyzanski S, et al. Patient tolerance and acceptance of unsedated ultrathin esophagoscopy. Gastrointest Endosc. 2002;55:620–3. [PubMed] [Google Scholar]
31. Wildi SM, Wallace MB, Glenn TF, et al. Accuracy of esophagoscopy performed by a non-physician endoscopist with a 4-mm diameter battery-powered endoscope. Gastrointest Endosc. 2003;57:305–10. [PubMed] [Google Scholar]
32. Saeian K, Staff DM, Vasilopoulos S, et al. Unsedated transnasal endoscopy accurately detects Barrett’s metaplasia and dysplasia. Gastrointest Endosc. 2002;56:472–8. [PubMed] [Google Scholar]
33. Jobe BA, Hunter JG, Chang EY, et al. Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening or surveillance for Barrett’s esophagus: A randomized and blinded comparison. Am J Gastroenterol. 2006;107:2160–6. [PubMed] [Google Scholar]
34. Atkinson M, Das A, Faulx A, et al. Ultrathin esophagoscopy in screening for Barrett’s esophagus at a Veterans Administration hospital: Easy access does not lead to referrals. Am J Gastroenterol. 2008;103:92–97. [PubMed] [Google Scholar]
35. Delvaux M, Gay G. Capsule endoscopy: Technique and indications. Best Practice & Research Clinical Gastroenterology. 2008;22:813–837. [PubMed] [Google Scholar]
36. Gralnek IM, Rabinovitz R, Afik D, et al. A simplified ingestion procedure for esophageal capsule endoscopy: initial evaluation in healthy volunteers. Endoscopy. 2006;38:913–918. [PubMed] [Google Scholar]
37. De Jonge PJF, Van Eijck BC, Geldof H, et al. Capsule endoscopy for the detection of oesophageal mucosal disorders: a comparison of two different ingestion protocols. Scand Journal of Gastroenterol. 2008;43:870–877. [PubMed] [Google Scholar]
38. Ramirez FC, Shaukat MS, Young MA, et al. Feasibility and safety of string, wireless capsule endoscopy in the diagnosis of Barrett’s esophagus. Gastrointest Endosc. 2005;61:741–6. [PubMed] [Google Scholar]
39. Ramirez FC, Akins R, Shaukat M. Screening of Barrett’s esophagus with string-capsule endoscopy: a prospective blinded study of 100 consecutive patients using histology as the criterion standard. Gastrointest Endosc. 2008;68:25–31. [PubMed] [Google Scholar]
40. Lin OS, Schembre DB, Mergener K, et al. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett’s esophagus in patients with chronic gastroesophageal reflux. Gastrointest Endosc. 2007;65:577–83. [PubMed] [Google Scholar]
41. Delvaux M, Papanikolaou IS, Fassler I, et al. Esophageal capsule endoscopy in patients with suspected esophageal disease: double blinded comparison with esophagogastroduodenoscopy and assessment of interobserver variability. Endoscopy. 2008;40:16–22. [PubMed] [Google Scholar]
42. Galmiche JP, Sacher-Huvelin S, Coron E, et al. Screening for esophagitis and Barrett’s esophagus with wireless esophageal capsule endoscopy: A multicenter prospective trial in patients with reflux symptoms. Am J Gastroenterol. 2008;103:538–545. [PubMed] [Google Scholar]
43. Hur C. Esophageal capsule endoscopy for Barrett’s esophagus screening: a hard pill to swallow? Clin Gastroenterol Hepatol. 2007;5:307–309. [PubMed] [Google Scholar]
